45.79USD-8.18%Mkt Cap: —P/E: —1d ago
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a pro…
Industry Peers
Health Information Services$38.07BUSDP/E 44.2
$40.77BUSDP/E 44.6
$11.74BUSDP/E 53.0
$11.05BUSD
$8.71BUSDP/E 38.9
$8.10BUSD
$7.14BUSDP/E 10.8
$4.76BUSDP/E 35.5
$4.62BUSDP/E 30.9
$3.96BUSD
$2.75BUSDP/E 97.7
$1.66BUSDP/E 43.4
$1.50BUSDP/E 36.5
$1.48BUSD
$1.28BUSD
$1.21BUSDP/E 59.0
$1.18BUSD
$870.57MUSD
$834.80MUSDP/E 39.7
$738.82MUSDP/E 74.8
Key Statistics
Company
Market Cap—
Enterprise Value2.36B $
Revenue (TTM)251.17M $
Gross Profit187.26M $
Net Income (TTM)-33.55M $
Revenue/Share5.071 USD
Last Price45.79 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees622
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-395.20
EV/Revenue9.39
P/S—
P/B9.56
EPS (TTM)-0.77
EPS (Forward)—
52W Range
45.643% of range50.71
52W High50.71 USD
52W Low45.64 USD
Profitability
Gross Margin74.56%
Oper. Margin-3.09%
EBITDA Margin-2.38%
Profit Margin-13.36%
ROE-18.21%
ROA-3.15%
Growth
Revenue Growth23.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF15.05M $
CapEx (TTM)—
FCF Margin7.26%
FCF Yield—
Net Debt-91.35M $
Net Debt/EBITDA15.31
Balance Sheet
Debt/Equity7.83
Current Ratio6.60
Quick Ratio4.79
Book Value/Sh4.776 USD
Cash/Share2.072 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.38.67M
Float52.62M
Insiders2.16%
Institutions99.10%
Technical
SMA 509.100 (+403.2%)
SMA 2007.353 (+522.7%)
Beta1.14
S&P 52W Chg18.16%
Avg Vol (30d)574
Avg Vol (10d)529
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—